Written by:Bilal HasdemirFact check:

Overview

What Is Chronic Lymphocytic Leukemia?

Chronic lymphocytic leukemia (CLL) is a cancer of abnormal mature B lymphocytes, a type of white blood cell that helps fight infection. These cells survive longer than they should and gradually build up in the blood, bone marrow and sometimes lymph nodes. CLL usually grows slowly, and many people have few symptoms for years. It mainly affects older adults, although it can occur at other ages.

Symptoms

Symptoms of Chronic Lymphocytic Leukemia

Many people have no noticeable symptoms at first, and CLL may be found during a routine blood test. When symptoms occur, they may result from abnormal lymphocytes, enlarged lymph nodes, anemia or a reduced ability to fight infections. Chronic lymphocytic leukemia symptoms can develop gradually, so report persistent or worsening changes to a healthcare professional.

  • Painless swollen lymph nodes
  • Ongoing fatigue
  • Frequent or hard-to-clear infections
  • Unexplained weight loss
  • Night sweats
  • Fever without a clear cause
  • Easy bruising or bleeding
  • Fullness under the ribs from an enlarged spleen

Causes

What Causes Chronic Lymphocytic Leukemia?

CLL develops when genetic changes cause mature B lymphocytes to survive longer and accumulate abnormally. These altered cells can crowd out healthy blood cells and interfere with normal immune function. In most cases, the specific trigger for the genetic changes is not known. Researchers continue to study how inherited and acquired changes may contribute to this chronic lymphocytic condition.

Risk Factors

Risk Factors for Chronic Lymphocytic Leukemia

  • Older age is the strongest known risk factor, because CLL is diagnosed most often in later adulthood.
  • Male sex is associated with a somewhat higher likelihood of developing CLL.
  • Having a close family member with CLL or a related lymphoid cancer increases risk.
  • Certain ancestral and geographic patterns are associated with different rates of CLL, although the reasons are not fully understood.

Having a risk factor does not mean that someone will develop CLL. Most people cannot identify a specific cause, and there is no known lifestyle change that prevents every case of chronic leukemia.

Side Effects & Complications

Complications and Treatment Side Effects

  • Recurrent or serious infections can occur when CLL or its treatment weakens immune defenses.
  • Anemia can cause tiredness, weakness or shortness of breath.
  • Low platelet counts can lead to easy bruising or bleeding.
  • Autoimmune destruction of red blood cells or platelets can worsen blood-count problems.
  • An enlarged spleen or lymph nodes may cause abdominal fullness, discomfort or pressure.

Possible treatment side effects and monitoring

  • Low blood counts may increase fatigue, infection risk or bleeding risk.
  • Infections may occur during or after some leukemia treatments.
  • Nausea, diarrhea or other digestive effects can occur with certain medicines.
  • Fatigue may develop from treatment, anemia or the disease itself.
  • Infusion reactions can occur with some antibody treatments.
  • Some targeted medicines may affect heart rhythm or cardiovascular health.
  • Tumor lysis can occur when treatment rapidly destroys many leukemia cells and requires careful monitoring.

Diagnosis & Staging

Diagnosis and Staging of Chronic Lymphocytic Leukemia

CLL is often suspected after a complete blood count shows an unusually high number of lymphocytes. Doctors can confirm the diagnosis by examining the cells with flow cytometry, which identifies their characteristic markers. Bone marrow testing, imaging scans or evaluation of a lymph node may be considered when the diagnosis is uncertain, symptoms need assessment or treatment planning requires more information.

How CLL staging works

Disease categoryTypical findingsTreatment significance
EarlyLymphocytosis with few or no enlarged lymph nodes, enlarged spleen or liver, anemia or low platelets.Many people can be monitored without immediate treatment if they feel well and blood counts remain stable.
IntermediateLymphocytosis with enlarged lymph nodes and/or an enlarged spleen or liver, without severe anemia or low platelets.The care team considers symptoms, blood-count trends and disease pace when deciding whether treatment is needed.
AdvancedAnemia or low platelet counts, often with enlarged lymph nodes, spleen or liver.Treatment is more commonly considered, but stage alone does not determine the best therapy.

Chromosome changes, gene mutations, lymphocyte markers, symptoms, blood counts and the pace of change can influence prognosis and treatment decisions. Rai and Binet categories help describe disease extent, but they do not predict every person’s course. These findings also help the hematology team decide whether leukemia treatment is needed now or whether monitoring remains appropriate.

Treatment Options

Treatment Options for Chronic Lymphocytic Leukemia

  • Active monitoring uses regular examinations and blood tests when stable disease does not require immediate treatment.
  • Targeted therapies block specific signals that help CLL cells survive or multiply.
  • Antibody immunotherapy helps the immune system recognize and attack abnormal B lymphocytes.
  • Chemotherapy may be used in selected situations, although targeted medicines are often preferred when appropriate.
  • Stem-cell or cellular therapy may be considered for difficult-to-treat, relapsed or high-risk disease.
  • Supportive care helps prevent or manage infections, anemia, bleeding, treatment effects and other symptoms.

Treatment decisions

Treatment depends on disease activity

Treatment is not always started immediately. It may be recommended when blood counts worsen, lymph nodes or the spleen continue to enlarge, symptoms become significant or the disease advances rapidly.

The hematology team selects therapy according to disease biology, previous treatment, other health conditions, drug interactions, patient preferences and goals of care. Because leukemia treatments can have different benefits and risks, the plan should be reviewed regularly as the disease changes.

Outlook and Prognosis

Outlook and Prognosis

CLL ranges from an indolent condition that can be monitored for years to a more active disease requiring treatment. Many people live with chronic leukemia for a long time, often experiencing periods of observation, treatment response or changes in therapy. The disease can sometimes return or become less responsive to treatment, so ongoing medical follow-up is important.

  • Stage and the presence of enlarged lymph nodes, spleen or liver can affect outlook.
  • Symptoms and changes in blood counts may indicate how active the disease is.
  • Genetic and molecular findings can help estimate disease behavior and treatment response.
  • The depth and length of response to treatment can influence future planning.
  • Age and overall health affect treatment choices, recovery and tolerance of side effects.

Survivorship & Follow-up

Survivorship and Follow-Up for CLL

  • Scheduled visits and blood counts help track disease activity and treatment effects.
  • The care team reviews changes in lymph nodes, the spleen and other symptoms.
  • Appointments include assessment for infections, treatment side effects and late effects.
  • Vaccination and preventive-care planning help reduce infection risks when appropriate.
  • Emotional, social and practical support needs can be addressed throughout follow-up.

Branches

2 topics